Literature DB >> 19268058

Montelukast versus inhaled corticosteroids as monotherapy for prevention of asthma: which one is best?

S Miceli Sopo1, R Onesimo, D Radzik, G Scala, F Cardinale.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19268058     DOI： 10.1016/s0301-0546(09)70248-4

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN： 0301-0546            Impact factor:   1.667


× No keyword cloud information.
  4 in total

Review 1.  Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children.

Authors:  Malcolm Brodlie; Atul Gupta; Carlos E Rodriguez-Martinez; Jose A Castro-Rodriguez; Francine M Ducharme; Michael C McKean
Journal:  Cochrane Database Syst Rev       Date:  2015-10-19

Review 2.  Clinical effectiveness and safety of montelukast in asthma. What are the conclusions from clinical trials and meta-analyses?

Authors:  Kam Lun Ellis Hon; Ting Fan Leung; Alexander K C Leung
Journal:  Drug Des Devel Ther       Date:  2014-06-26       Impact factor: 4.162

3.  A comparison of efficacy and safety of complementary and alternative therapies for children with asthma: A protocol for systematic review and meta analysis.

Authors:  Peng Zhou; Leiming Xi; Hongan He; Baoqing Zhang; Yanning Li
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

4.  Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma.

Authors:  Alessandra Scaparrotta; Sabrina Di Pillo; Marina Attanasi; Daniele Rapino; Anna Cingolani; Nicola Pietro Consilvio; Marcello Verini; Francesco Chiarelli
Journal:  Multidiscip Respir Med       Date:  2012-07-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.